Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real-world study.
Korotaeva T, Dina O, Holdsworth E, Fallon L, Milligan G, Meakin S, Wang L, Vasilescu R, Cappelleri JC, Deodhar A. Korotaeva T, et al. Among authors: vasilescu r. Clin Rheumatol. 2021 Dec;40(12):4915-4926. doi: 10.1007/s10067-021-05864-8. Epub 2021 Jul 28. Clin Rheumatol. 2021. PMID: 34319479 Free PMC article.
Correction to: Investigating diagnosis, treatment, and burden of disease in patients with ankylosing spondylitis in Central Eastern Europe and the United States: a real‑world study.
Korotaeva T, Dina O, Holdsworth E, Fallon L, Milligan G, Meakin S, Wang L, Vasilescu R, Cappelleri JC, Deodhar A. Korotaeva T, et al. Among authors: vasilescu r. Clin Rheumatol. 2022 Apr;41(4):1269. doi: 10.1007/s10067-022-06069-3. Clin Rheumatol. 2022. PMID: 35084603 Free PMC article. No abstract available.
Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study.
Pavelka K, Szekanecz Z, Damjanov N, Majdan M, Nasonov E, Mazurov V, Fabo T, Bananis E, Jones H, Szumski A, Tang B, Kotak S, Koenig AS, Vasilescu R. Pavelka K, et al. Among authors: vasilescu r. Clin Rheumatol. 2013 Sep;32(9):1275-81. doi: 10.1007/s10067-013-2240-4. Epub 2013 May 11. Clin Rheumatol. 2013. PMID: 23666316 Clinical Trial.
Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
Pavelka K, Akkoç N, Al-Maini M, Zerbini CAF, Karateev DE, Nasonov EL, Rahman MU, Pedersen R, Dinh A, Shen Q, Vasilescu R, Kotak S, Mahgoub E, Vlahos B. Pavelka K, et al. Among authors: vasilescu r. Rheumatol Int. 2017 Sep;37(9):1469-1479. doi: 10.1007/s00296-017-3749-7. Epub 2017 Jun 9. Rheumatol Int. 2017. PMID: 28597306 Clinical Trial.
Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment.
Taylor PC, Alten R, Gomez-Reino JJ, Caporali R, Bertin P, Sullivan E, Wood R, Piercy J, Vasilescu R, Spurden D, Alvir J, Tarallo M. Taylor PC, et al. Among authors: vasilescu r. RMD Open. 2018 Mar 17;4(1):e000615. doi: 10.1136/rmdopen-2017-000615. eCollection 2018. RMD Open. 2018. PMID: 29593881 Free PMC article.
Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice.
Taylor PC, Alten R, Reino JJG, Caporali R, Bertin P, Sullivan E, Wood R, Piercy J, Vasilescu R, Spurden D, Alvir J, Tarallo M. Taylor PC, et al. Among authors: vasilescu r. Patient Prefer Adherence. 2018 Oct 4;12:2007-2014. doi: 10.2147/PPA.S170054. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 30323570 Free PMC article.
27 results